These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 23845207)

  • 1. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
    Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
    J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between TNFSF13B polymorphisms and primary Sjögren's syndrome susceptibility in primary Sjögren's syndrome patients: A meta-analysis.
    Zheng A; Hu N; Xu J; Yuan Y; Zhang S; Chen W; Bai Y; Sun H
    Immun Inflamm Dis; 2023 Dec; 11(12):e1103. PubMed ID: 38156381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome.
    Nossent JC; Lester S; Zahra D; Mackay CR; Rischmueller M
    Rheumatology (Oxford); 2008 Sep; 47(9):1311-6. PubMed ID: 18617551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Variants of the
    Flessa CM; Zampeli E; Evangelopoulos ME; Natsis V; Bodewes ILA; Huijser E; Versnel MA; Moutsopoulos HM; Mavragani CP
    Front Immunol; 2022; 13():836824. PubMed ID: 35371038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical atherosclerosis profiles in rheumatoid arthritis and primary Sjögren's syndrome: the impact of BAFF genetic variations.
    Kintrilis N; Gravani F; Rapti A; Papaioannou M; Flessa CM; Nezos A; Antypa E; Papadaki I; Karageorgas Τ; Moutsopoulos HM; Mavragani CP
    Rheumatology (Oxford); 2023 Feb; 62(2):958-968. PubMed ID: 35689637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome.
    Gottenberg JE; Sellam J; Ittah M; Lavie F; Proust A; Zouali H; Sordet C; Sibilia J; Kimberly RP; Mariette X; Miceli-Richard C
    Arthritis Res Ther; 2006; 8(1):R30. PubMed ID: 16507129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell activating factor and related genetic variants in lupus related atherosclerosis.
    Theodorou E; Nezos A; Antypa E; Ioakeimidis D; Koutsilieris M; Tektonidou M; Moutsopoulos HM; Mavragani CP
    J Autoimmun; 2018 Aug; 92():87-92. PubMed ID: 29859654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of TNFSF13B polymorphisms and BAFF expression in rheumatoid arthritis and primary Sjögren's syndrome patients.
    Santillán-López E; Muñoz-Valle JF; Oregon-Romero E; Espinoza-García N; Treviño-Talavera BA; Salazar-Camarena DC; Marín-Rosales M; Cruz A; Alvarez-Gómez JA; Sagrero-Fabela N; Cerpa-Cruz S; Palafox-Sánchez CA
    Mol Genet Genomic Med; 2022 Jun; 10(6):e1950. PubMed ID: 35411715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TREX1 variants in Sjogren's syndrome related lymphomagenesis.
    Nezos A; Makri P; Gandolfo S; De Vita S; Voulgarelis M; Crow MK; Mavragani CP
    Cytokine; 2020 Aug; 132():154781. PubMed ID: 31326279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTHFR gene variants and non-MALT lymphoma development in primary Sjogren's syndrome.
    Fragkioudaki S; Nezos A; Souliotis VL; Chatziandreou I; Saetta AA; Drakoulis N; Tzioufas AG; Voulgarelis M; Sfikakis PP; Koutsilieris M; Crow MK; Moutsopoulos HM; Mavragani CP
    Sci Rep; 2017 Aug; 7(1):7354. PubMed ID: 28779180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of genetic variation in B-cell activating factor with chronic hepatitis B virus infection.
    Han Q; Yang C; Li N; Li F; Sang J; Lv Y; Zhao W; Li C; Liu Z
    Immunol Lett; 2017 Aug; 188():53-58. PubMed ID: 28627389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation.
    Papageorgiou A; Mavragani CP; Nezos A; Zintzaras E; Quartuccio L; De Vita S; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    Arthritis Rheumatol; 2015 Oct; 67(10):2732-41. PubMed ID: 26097183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic associations to germinal centre formation in primary Sjogren's syndrome.
    Reksten TR; Johnsen SJ; Jonsson MV; Omdal R; Brun JG; Theander E; Eriksson P; Wahren-Herlenius M; Jonsson R; Nordmark G
    Ann Rheum Dis; 2014 Jun; 73(6):1253-8. PubMed ID: 23606706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
    Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
    Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
    Front Immunol; 2021; 12():673658. PubMed ID: 34012457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
    J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis.
    Nezos A; Mavragani CP
    J Immunol Res; 2015; 2015():754825. PubMed ID: 26550578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
    Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni Bocci E; Carubbi F; Maset M; Gregoraci G; Della Mea V; Salvin S; De Marchi G; Luciano N; Colafrancesco S; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
    J Autoimmun; 2014 Jun; 51():75-80. PubMed ID: 24231556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
    Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
    Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAS -670A>G promoter polymorphism is associated with soluble Fas levels in primary Sjögren's syndrome.
    Treviño-Talavera BA; Palafox-Sánchez CA; Muñoz-Valle JF; Orozco-Barocio G; Navarro-Hernández RE; Vázquez-Del Mercado M; García de la Torre I; Oregon-Romero E
    Genet Mol Res; 2014 Jul; 13(3):4831-8. PubMed ID: 25062418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.